MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma

被引：0
作者：
Yu-Xiang Lin
Jun-Yong Pan
Wen-Du Feng
Tian-Cong Huang
Cheng-Zong Li
机构：
[1] The Second Affiliated Hospital of Fujian Medical University (Donghai District),Department of Hepatobiliary and Pancreatic Surgery
[2] The Second Affiliated Hospital of Fujian Medical University,Central Supply Service Department
来源：
European Journal of Medical Research | / 28卷
关键词：
Hepatocellular carcinoma; MRPL48; Prognostic value; Biomarker; Biological functions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival
    Lu, Guifang
    Shan, Tao
    He, Shuixiang
    Ren, Mudan
    Zhu, Meng
    Hu, Yannan
    Lu, Xinlan
    Zhang, Dan
    ONCOLOGY REPORTS, 2013, 30 (05) : 2238 - 2244
  • [32] SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
    Ye, Mu
    Wang, Sheng
    Qie, Jing-Bo
    Sun, Pei-Long
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma
    Gao, Xiaoge
    Ren, Xin
    Wang, Feitong
    Ren, Xinxin
    Liu, Mengchen
    Cui, Guozhen
    Liu, Xiangye
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [34] LZTR1 expression as a novel predictive biomarker for early recurrence of hepatocellular carcinoma
    Xi Yu
    Shuqi Mao
    Yuying Shan
    Kedan Cen
    Caide Lu
    Yi Huang
    European Journal of Medical Research, 30 (1)
  • [35] CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
    Xie, Xing-Wei
    Jiang, Shan-Shan
    Li, Xiang
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 7
  • [36] Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
    Su, Wen-Jing
    Lu, Pei-Zhi
    Wu, Yong
    Kalpana, Kumari
    Yang, Cheng-Kun
    Lu, Guo-Dong
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [37] Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
    Zhen Lin
    Yi-Zhao Xie
    Ming-Chun Zhao
    Pin-Pin Hou
    Juan Tang
    Guang-Liang Chen
    Cancer Cell International, 21
  • [38] H2AFX might be a prognostic biomarker for hepatocellular carcinoma
    Hu, Hailiang
    Zhong, Tao
    Jiang, Suwei
    CANCER REPORTS, 2023, 6 (01)
  • [39] Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
    Lin, Zhen
    Xie, Yi-Zhao
    Zhao, Ming-Chun
    Hou, Pin-Pin
    Tang, Juan
    Chen, Guang-Liang
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [40] Alpha-fetoprotein:A controversial prognostic biomarker for small hepatocellular carcinoma
    Mohamed Asrih
    Sébastien Lenglet
    Franois Mach
    Fabrizio Montecucco
    World Journal of Gastroenterology, 2013, (03) : 328 - 330
12345